查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771529

全球主动脉髂动脉阻塞性疾病（髂动脉疾病）治疗市场：市场规模、份额、趋势分析（按设备类型、程序、最终用途和地区）、细分市场预测（2025-2030 年）

Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size, Share & Trends Analysis Report By Device Type (Endovascular Devices, Surgical Devices), By Procedure, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10个工作天内

价格

主髂动脉阻塞性疾病治疗市场概述

2024 年全球主髂动脉阻塞性疾病（髂动脉疾病）治疗市值估计为 21.5 亿美元，预计 2030 年将达到 29.5 亿美元，2025 年至 2030 年期间的复合年增长率为 5.5%。主髂动脉阻塞性疾病 (AIOD) 是一种腹部和骨盆大动脉（尤其是主动脉和髂动脉）变窄或阻塞，导致腿部血流减少的疾病。

周边动脉疾病(PAD) 盛行率的不断上升是推动市场成长的关键因素之一。根据美国心臟协会 (美国 Heart Association, Inc.) 2023 年 6 月发表的报导，周边动脉疾病(PAD) 影响着全球约 2 亿人。它是主动脉阻塞性疾病 (AIOD) 发展的重要因素。随着老化、糖尿病和吸烟等因素导致周边动脉疾病 (PAD) 盛行率上升，对 AIOD 有效治疗的需求也日益增长。这种日益增长的需求推动了髂动脉支架置入术和血管内治疗等微创手术的普及，这些手术有助于恢復正常血流，并缓解腿部疼痛和活动受限等症状。

政府倡议不断推高市场成长 根据 2023 年 6 月发表的一篇 Congress.Gov报导，美国政府透过引入《综合动脉和静脉 (ARC) 法案》，在加强周边动脉疾病(PAD)（主动脉闭塞性疾病的主要原因）的早期发现和管理方面迈出了重要一步。该法案提案对《社会安全法》进行修订，旨在允许被确定为高风险的 Medicare 和 Medicaid 受益人免费接受 PAD 筛检。涵盖的诊断方法包括踝臂指数 (ABI) 测试和动脉双重扫描，这些对于识别 PAD 和评估主动脉髂区疾病的严重程度至关重要。 ARC 法案授权从 2024 年到 2028 年每年拨款 600 万美元，旨在改善早期诊断和及时干预，从而可能减轻晚期闭塞性疾病的负担，并增加对髂动脉置入术和重组治疗等标靶治疗方案的需求。该倡议旨在促进预防性护理并支持更广泛地获得基本血管医疗服务。

此外，根据美国心臟学会基金会2025年2月发表的一篇报导，最近重新提交的《家庭永续心肺復健服务法案》(HR 783)提案将居家心肺復健服务永久纳入医疗保险覆盖范围。该法案旨在提高基本復健服务的可近性，特别是对于行动不便或居住在偏远地区的患者。这项旨在促进復健护理可近性的措施将有助于有效管理周边动脉疾病(PAD) 及其相关疾病，包括主动脉闭塞性疾病，最终改善患者预后，并推动市场对先进治疗方案的需求。

主髂动脉阻塞性疾病（髂动脉疾病）治疗技术的进步将推动市场成长。例如，2025年1月，Bentley Medical在2025年莱比锡介入课程（LINC）上推出了BeFlow髂动脉覆膜支架系统，标誌着主髂动脉阻塞性疾病治疗领域的重大进展。 BeFlow支架专为治疗复杂的髂动脉病变而设计，可提高长期通畅性和耐用性，并符合欧洲血管外科学会（ESS）关于对严重狭窄或闭塞的髂动脉使用覆膜支架的指南。 BeFlow支架的直径为7-10毫米，长度为37-57毫米，旨在提供一种经济高效的裸金属支架替代方案，并改善患者获得先进血管介入治疗的途径。

目录

第一章 分析方法与范围

第二章执行摘要

3. 全球主髂动脉阻塞性疾病（髂动脉疾病）治疗市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第四章。主动脉髂动脉阻塞性疾病（髂动脉疾病）治疗市场：按设备类型的估计和趋势分析

  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场：仪表板，依设备类型
  • 主动脉髂动脉阻塞性疾病（髂动脉疾病）治疗市场：依装置类型分類的差异分析
  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场规模预测及趋势分析（2018-2030年）
  • 血管内装置
  • 手术设备

第五章。主动脉髂动脉阻塞性疾病（髂动脉疾病）治疗市场：按程序进行的估计和趋势分析

  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场：依程序分類的仪表板
  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场：依程序进行的变化分析
  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场规模预测及趋势分析（2018-2030年）
  • 血管内手术
  • 混合手术
  • 开放性手术

6. 主动脉髂动脉阻塞性疾病（髂动脉疾病）治疗市场：依最终用途的估计与趋势分析

  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场：仪表板、依最终用途
  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场：依最终用途分類的销售分析
  • 主髂动脉阻塞性疾病（髂动脉疾病）治疗市场规模预测与最终用途趋势分析（2018-2030）
  • 医院
  • 门诊设施
  • 其他的

7. 主动脉髂动脉阻塞性疾病（髂动脉疾病）治疗市场：区域估计与趋势分析（按国家、设备类型、程序、最终用途）

  • 全球主髂动脉阻塞性疾病（髂动脉疾病）治疗市场：按地区分類的仪表板
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要製造商的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 主要客户
    • 主要企业分析（2024年）
    • BD.
    • Bentley InnoMed
    • Scitech Medical
    • Abbott
    • Boston Scientific Corporation
    • WL Gore &Associates, Inc.
    • Medtronic
    • Cook
    • Terumo Corporation
    • iVascular
    • Getinge AB
    • Biotronik SE &Co KG
Product Code: GVR-4-68040-602-6

Aorto-Iliac Occlusive Disease Treatment Market Summary

The global aorto-iliac occlusive disease (iliac disease) treatment market size was estimated at USD 2.15 billion in 2024 and is projected to reach USD 2.95 billion by 2030, growing at a CAGR of 5.5% from 2025 to 2030. Aorto-Iliac Occlusive Disease (AIOD) is a condition where the large arteries in the abdomen and pelvis, specifically the aorta and iliac arteries, become narrowed or blocked, reducing blood flow to the legs.

The increasing prevalence of Peripheral Artery Disease (PAD) is one of the key factors driving the market's growth. According to the American Heart Association, Inc. article published in June 2023, Peripheral artery disease (PAD) affects an estimated 200 million people worldwide. It significantly contributes to developing Aorto-Iliac Occlusive Disease (AIOD). The growing prevalence of PAD, driven by factors such as aging populations, diabetes, and smoking, has increased the need for effective treatments for AIOD. This rising demand drives the adoption of minimally invasive procedures, including iliac artery stenting and endovascular therapies, which help restore proper blood flow and alleviate symptoms like leg pain and limited mobility.

Increasing government initiatives drive the market growth. According to the Congress.Gov article published in June 2023, the U.S. government took a significant step toward enhancing early detection and management of Peripheral Artery Disease (PAD), a primary contributor to Aorto-Iliac Occlusive Disease, through the introduction of the Arterial and Venous Comprehensive (ARC) Act. This legislation proposes amendments to the Social Security Act, aiming to ensure that Medicare and Medicaid beneficiaries identified as high-risk can access PAD screening without incurring out-of-pocket costs. Covered diagnostic procedures include ankle-brachial index (ABI) tests and arterial duplex scans, critical for identifying PAD and assessing disease severity in the aorto-iliac region. Authorizing USD 6 million in annual funding from 2024 to 2028, the ARC Act seeks to improve early diagnosis and timely intervention, potentially reducing the burden of advanced occlusive conditions and boosting the demand for targeted treatment options such as iliac stenting and revascularization therapies. This initiative promotes preventive care and supports broader access to essential vascular health services.

Moreover, as per the American College of Cardiology Foundation. Article published in February 2025, the Sustainable Cardiopulmonary Rehabilitation Services in the Home Act (H.R. 783), recently reintroduced, proposes to make the Medicare coverage for in-home cardiopulmonary rehabilitation services permanent. This legislative move is designed to enhance access to essential rehabilitation, especially for patients with mobility limitations or those residing in remote areas. Facilitating easier access to rehabilitation care, this initiative supports the effective management of peripheral artery disease (PAD) and related conditions, including Aorto-Iliac Occlusive Disease, ultimately improving patient outcomes and driving demand for advanced treatment options in the market.

Technological advancements in aorto-iliac occlusive disease (iliac disease) treatment drive the market's growth. For instance, in January 2025, Bentley Medical introduced the BeFlow iliac covered stent system at the Leipzig Interventional Course (LINC) 2025, marking a significant advancement in treating aorto-iliac occlusive disease. Designed to address complex iliac lesions, the BeFlow stent offers enhanced long-term patency and durability, aligning with European Society for Vascular Surgery guidelines that recommend covered stents for heavily stenosed or occluded iliac arteries. Available in diameters ranging from 7 to 10 mm and lengths of 37 and 57 mm, the BeFlow stent aims to provide a cost-effective alternative to bare metal stents, improving patient access to advanced vascular interventions.

Global Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and analyzes the industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global aorto-iliac occlusive disease treatment market report based on device type, procedure, end use, and region:

  • Device Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Endovascular Devices
    • Balloon Angioplasty Devices
    • Atherectomy Systems
    • Stents
    • Self-Expanding Stents
    • Balloon-Expandable Stents
    • Covered Stent Grafts
    • Bifurcated Aortic Stent Grafts
  • Surgical Devices
  • Procedure Outlook (Revenue, USD Million, 2018 - 2030)
  • Endovascular Procedures
    • Balloon Angioplasty
    • Primary Stenting
    • Kissing Stents
    • Covered Stent Grafts
    • Endovascular Aortic Repair (EVAR)
  • Hybrid Procedures
  • Open Surgical Procedures
  • Procedure Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Outpatient Facilities
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device Type
    • 1.2.2. Procedure
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Device Type Segment
    • 2.2.2. Procedure Segment
    • 2.2.3. End Use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of PAD
      • 3.2.1.2. Rising government initiatives
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with the devices and procedures
      • 3.2.2.2. Lack of awareness and early diagnosis in rural regions
  • 3.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Estimates & Trend Analysis

  • 4.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Dashboard
  • 4.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Movement Analysis
  • 4.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by Device Type, 2018 to 2030 (USD Million)
  • 4.4. Endovascular Devices
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Balloon Angioplasty Devices Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Atherectomy Systems Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Stents Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.4.2. Self-Expanding Stents
        • 4.4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.4.3. Balloon-Expandable Stents
        • 4.4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.4.4. Covered Stent Grafts
        • 4.4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.4.5. Bifurcated Aortic Stent Grafts
        • 4.4.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Surgical Devices
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Estimates & Trend Analysis

  • 5.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Dashboard
  • 5.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Movement Analysis
  • 5.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
  • 5.4. Endovascular Procedures
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.2. Balloon Angioplasty Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.3. Primary Stenting Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.4. Kissing Stents Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.5. Covered Stent Grafts Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.6. Endovascular Aortic Repair (EVAR) Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Hybrid Procedures
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Open Surgical Procedures
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Estimates & Trend Analysis

  • 6.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Dashboard
  • 6.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Movement Analysis
  • 6.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by End Use , 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Outpatient Facilities
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Regional Estimates & Trend Analysis by Country, Device Type, Procedure & End Use

  • 7.1. Global Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company analysis, 2024
    • 8.3.4. BD.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bentley InnoMed
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Scitech Medical
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Boston Scientific Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. W. L. Gore & Associates, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Medtronic
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Cook
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Terumo Corporation
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. iVascular
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Getinge AB
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Biotronik SE & Co KG
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 4 Global aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 5 Global aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030
  • Table 6 Global aorto-iliac occlusive disease (iliac disease) treatment market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 9 North America aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 10 North America aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 12 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 13 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 15 Canada aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 16 Canada aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 18 Mexico aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 19 Mexico aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 22 Europe aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 23 Europe aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 25 UK aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 26 UK aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 28 Germany aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 29 Germany aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 31 France aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 32 France aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 34 Italy aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 35 Italy aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 37 Spain aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 38 Spain aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Denmark aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 40 Denmark aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 41 Denmark aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Sweden aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 43 Sweden aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 44 Sweden aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Norway aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 46 Norway aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 47 Norway aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 53 Japan aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 54 Japan aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 56 China aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 57 China aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 59 India aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 60 India aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
  • Table 62 Australia aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 63 Australia aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 64 Australia aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Thailand aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 66 Thailand aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 67 Thailand aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 68 South Korea aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 69 South Korea aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 70 South Korea aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
  • Table 72 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 73 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 74 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Brazil aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 76 Brazil aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 77 Brazil aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Argentina aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 79 Argentina aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 80 Argentina aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 81 MEA aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
  • Table 82 MEA aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 83 MEA aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 84 MEA aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 85 South Africa aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 86 South Africa aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 87 South Africa aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 91 UAE aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 92 UAE aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 93 UAE aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
  • Table 96 Kuwait aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Participant's overview
  • Table 98 Financial performance
  • Table 99 Key companies undergoing expansions
  • Table 100 Key companies undergoing acquisitions
  • Table 101 Key companies undergoing collaborations
  • Table 102 Key companies launching new products
  • Table 103 Key companies undergoing partnerships
  • Table 104 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Aorto-iliac occlusive disease (iliac disease) treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Aorto-iliac occlusive disease (iliac disease) treatment market revenues, 2024 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Aorto-iliac occlusive disease (iliac disease) treatment market Device type outlook:
  • Fig. 14 Aorto-iliac occlusive disease (iliac disease) treatment market: Device type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global endovascular devices market, 2018 - 2030 (USD Million)
  • Fig. 17 Global balloon angioplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 18 Global atherectomy systems market, 2018 - 2030 (USD Million)
  • Fig. 19 Global stents market, 2018 - 2030 (USD Million)
  • Fig. 20 Global self-expanding stents market, 2018 - 2030 (USD Million)
  • Fig. 21 Global balloon-expandable stents market, 2018 - 2030 (USD Million)
  • Fig. 22 Global covered stent grafts market, 2018 - 2030 (USD Million)
  • Fig. 23 Global bifurcated aortic stent grafts market, 2018 - 2030 (USD Million)
  • Fig. 24 Global surgical devices market, 2018 - 2030 (USD Million)
  • Fig. 25 Aorto-iliac occlusive disease (iliac disease) treatment market Procedure outlook:
  • Fig. 26 Aorto-iliac occlusive disease (iliac disease) treatment market: Procedure movement analysis
  • Fig. 27 Global endovascular procedures market, 2018 - 2030 (USD Million)
  • Fig. 28 Global balloon angioplasty market, 2018 - 2030 (USD Million)
  • Fig. 29 Global primary stenting market, 2018 - 2030 (USD Million)
  • Fig. 30 Global kissing stents market, 2018 - 2030 (USD Million)
  • Fig. 31 Global covered stent grafts market, 2018 - 2030 (USD Million)
  • Fig. 32 Global endovascular aortic repair (EVAR) market, 2018 - 2030 (USD Million)
  • Fig. 33 Global hybrid procedures market, 2018 - 2030 (USD Million)
  • Fig. 34 Global open surgical procedures market, 2018 - 2030 (USD Million)
  • Fig. 35 Aorto-iliac occlusive disease (iliac disease) treatment market End use outlook:
  • Fig. 36 Aorto-iliac occlusive disease (iliac disease) treatment market: End use movement analysis
  • Fig. 37 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 38 Global outpatient facilities market, 2018 - 2030 (USD Million)
  • Fig. 39 Global others market, 2018 - 2030 (USD Million)
  • Fig. 40 Regional market place: Key takeaways
  • Fig. 41 North America aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Mexico aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 47 UK aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 France aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 China aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 India aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 MEA aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 Market Participant Categorization
  • Fig. 62 Strategy mapping